The management of intraocular retinoblastoma is rapidly changing, and even recent reviews
on the subject are behind existing practices. The 4 authors of this report collectively …

Objective: To determine whether intra-arterial chemotherapy is safe and effective in
advanced intraocular retinoblastoma. Retinoblastoma often presents with advanced …

Objective To describe tumor control following intra-arterial chemotherapy (IAC) for
retinoblastoma. Methods A retrospective interventional series in which 17 patients were …

PURPOSE: To report on our 3-year experience with the use of superselective ophthalmic
artery infusion of chemotherapy as initial, primary treatment for intraocular retinoblastoma …

Purpose Hereditary retinoblastoma (Rb) survivors have increased risk of subsequent
malignant neoplasms (SMNs). Previous studies reported elevated radiotherapy (RT)-related …

These and related research efforts reveal novel data that enhance our understanding of the
biology of retinoblastoma. These observations may facilitate new therapeutic approaches to …

Purpose To report on the influence of ophthalmic artery chemosurgery (OAC) on enucleation
rates, ocular and patient survival from metastasis and impact on practice patterns at …

Background To evaluate the occurrence of second malignant neoplasms (SMN) following
chemoreduction (CRD) with carboplatin, vincristine, and etoposide (CEV) as frontline …

About every 10 years a new book appears on any given medical specialty subject. Naturally,
this is not because the entire body of knowledge in that specialty is overhauled every 10 …

Objective Report on the 7-year experience with bilateral ophthalmic artery chemosurgery
(OAC-Tandem therapy) for bilateral retinoblastoma. Design Retrospective, single institution …